Abstract:Purpose/Objective: (64)Cu-diacetyl-bis(N4-methylthiosemicarbazone) (64Cu-ATSM) is a recently developed PET imaging marker for tumor hypoxia. However, its accuracy, reliability, and sensitivity have not been fully characterized in vivo. Also, activities from intravascular (64) Cu-ATSM that are not related to hypoxia, can also contribute to the PET signal. The purpose of this study is to validate its ability of hypoxia marker in animal mammary tumor model by comparing to immunostaining of a well-known hypoxia marker, EF5, and further characterize the dynamic uptake of 64Cu-ATSM in tumors using compartmental modeling to separate the intravascular signal contribution. Materials/Methods: R3230 mammary adenocarcinoma (R3230Ac) was used as tumor model and was implanted in the flank of Fisher344 rat. A dynamic (64) Cu-ATSM microPET scan was performed with a microPET R4 system. Tumor/muscle ratio and time activity curves were acquired from PET imaging. To validate the spatial correlation between (64) Cu-ATSM uptake and hypoxia area, EF5 and a vascular perfusion marker, Hoechst33342, were also administrated into the same animal during microPET scanning for subsequent histological imaging. Electronic autoradiography was conducted on tumor sections from the same animals. Images from microPET, autoradiography, EF5 immunostaining, Hoechst vascular perfusion, and H&E histology were aligned, and the distribution of (64) Cu-ATSM in the tumor was compared to the EF5/Hoechst fluorescent images. To further characterize the dynamic uptake of (64) Cu-ATSM in the tumor, a two-compartment model was used. In the model, the 64Cu-ATSM concentration is separated into an intravascular concentration (Cp) with vascular volume fraction (Vp) and extravascular concentration (Ce) with effective interstitial volume fraction (Ve). The transfer between the intra- and extra-vascular compartments is described by rate constant k(in) and k(out). After non-linear least square (NLLS) fitting to the dynamic scan data, the overall radioisotope signal in the tumor was separated into intravascular and extravascular components. Vascular volume fraction Vp and rate constant k were also obtained from the fitting. Results: The tumor-muscle ratio (T/M) of (64) Cu-ATSM measured by microPET in R3230Ac was 2.23 ± 0.11, indicating higher uptake in the tumor. The comparison between autoradiography and EF5/Hoechst staining showed high correlations between (64) Cu-ATSM uptake and hypoxia area (image correlation coefficient = 0.76). The area fraction of (64) Cu-ATSM uptake closely followed the area fraction of EF5 staining (0.24 ± 0.04 vs. 0.21 ± 0.03). The (64) Cu-ATSM uptake curves from PET imaging were fitted well by a two-compartment model for the R3230Ac tumor. The time courses of the intravascular and extravascular (64) Cu-ATSM signals were obtained from the NLLS fitting. Vascular volume fraction (Vp) and transfer constant (kin) were (2.50 ± 0.15) % and 0.045 ± 0.001 1/min, respectively. Conclusions: The distribution of (64) Cu-ATSM is closely correlated to tumor hypoxia in R3230Ac tumor. The uptake of (64)Cu-ATSM in R3230Ac can be also characterized by a compartmental model, which can effectively remove the intravascular radioisotope signal from the overall tissue signals, reflecting more accurately the tissue uptake and tumor hypoxia. The calculated tumor vascular volume fraction and transfer rate constant can be used to characterize the change of tumor hypoxia in the future study.

Monitoring the Effect of Mild Hyperthermia on Tumour Hypoxia by Cu-Atsm Pet Scanning

Small-Animal PET of Tumor Damage Induced by Photothermal Ablation with 64Cu-Bis-dota-hypericin

(64) Cu-Atsm Micropet Imaging Of Tumor Hypoxia In Mammary Tumor Model: Compartmental Modeling And Immunohistochemistry Analysis

Preliminary research of preparation of 64Cu-ATSM and its small animal scanning

The Effect of Mild Temperature Hyperthermia on Tumour Hypoxia and Blood Perfusion: Relevance for Radiotherapy, Vascular Targeting and Imaging.

Changes in Tumor Hypoxia Induced by Mild Temperature Hyperthermia As Assessed by Dual-Tracer Immunohistochemistry.

Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.

18F-HX4/18F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice

Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms

A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: Analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy

Alteration of Hypoxia and Glucose Metabolism Measured by 18F-Fmiso and 18F-Fdg Micropet/Ct Imaging During Anti-Angiogenic Therapy

Quantitative Ultrasound for Evaluation of Tumour Response to Ultrasound-Microbubbles and Hyperthermia

Multimodal PET/MRI Imaging Results Enable Monitoring the Side Effects of Radiation Therapy

Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM

Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma

Experimental Research for the Evaluation of Radiotherapeutic Response with 99Tcm-Hl91 Hypoxia Imaging

Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy Via Noninvasive Pet Molecular Imaging Strategies of Multifactorial Bioparameters

Multi-parameter MRI to Investigate Vasculature Modulation and Photo-Thermal Ablation Combination Therapy Against Cancer.

Application of Multiparametric Magnetic Resonance Imaging to Monitor the Early Antitumor Effect of CuS @ GOD Nanoparticles in a 4 T1 Breast Cancer Xenograft Model

Apoptosis Imaging with 18F-Ml-10 Micropet/Ct for Early Prediction of Response to Treatment in A Human Pancreatic Tumor Xenograft Model

Precision Nanomedicine Using Dual PET and MR Temperature Imaging-Guided Photothermal Therapy.